ZINC00881524, as a ROCK inhibitor, is primarily used in research focused on understanding cellular processes related to the Rho-associated protein kinase (ROCK) pathway. It is applied in studies investigating cell morphology, motility, and cytoskeletal organization, as ROCK plays a critical role in these functions. Additionally, it is utilized in exploring potential therapeutic applications for conditions such as cardiovascular diseases, glaucoma, and neurodegenerative disorders, where ROCK signaling is implicated. Its ability to modulate ROCK activity makes it a valuable tool in drug discovery and development, particularly in targeting diseases associated with abnormal cell proliferation and tissue remodeling.